Navigation Links
MSU to lead new global food security effort
Date:8/6/2012

EAST LANSING, Mich. Michigan State University will use a $7.3 million federal grant to cultivate the next generation of agricultural scientists in Africa and Asia, in hopes of improving food security and nutrition there.

The new Borlaug Higher Education Agricultural Research and Development program, named after Nobel Peace Prize Laureate Norman Borlaug, is funded by the U.S. Agency for International Development's Bureau for Food Security. Part of Feed the Future, the government's global hunger and food security initiative, the program will strengthen agricultural research institutions and support long-term training of agricultural researchers at the master's- and doctoral-degree levels.

"MSU has 50-plus years of engagement in Africa, and we're currently managing several M.S. and Ph.D. training programs whose objectives and program design are similar to those of this initiative," said Eric Crawford, professor of agricultural, food and resource economics. "MSU faculty is well versed in planning, designing and managing training and human capacity-building programs, especially in plant breeding, food science and food security, which are key areas of Feed the Future."

Crawford, who also serves as co-director of MSU's Food Security Group, and Frederik Derksen, chairperson of MSU's Department of Food Science and Human Nutrition, housed in the College of Agriculture and Natural Resources, will lead the effort.

The program will begin in Ghana, Uganda, Mali, Mozambique and Bangladesh with potential to expand to other Feed the Future countries, Crawford said. The five countries have similar priorities: increase agricultural productivity; reduce trade and transportation barriers; develop sound market-based principles for agriculture; accelerate rural growth and development; and improve nutrition.

Starting in fall 2013, the first cohort of students will comprise 30 master's degree candidates and 10 doctoral degree candidates, Cr
'/>"/>

Contact: Kristen Parker
kristen.parker@cabs.msu.edu
517-353-8942
Michigan State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research links extreme summer heat events to global warming
2. Global CO2 emissions continue to increase
3. Stanford researchers calculate global health impacts of the Fukushima nuclear disaster
4. Global warming harms lakes
5. How to make global fisheries worth 5 times more: UBC research
6. ASU ecologist receives prestigious global award for water research
7. NOAA plankton surveys, second longest in the North Atlantic, add to new global effort
8. No matter the drilling method, natural gas is a much-needed tool to battle global warming
9. Building global collaboration for biodiversity intelligence
10. Revealing climate change website wins global award
11. Gut microbes battle a common set of viruses shared by global populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... , July 8, 2015 Summary ... and the fourth most fatal, with a mortality rate ... poor prognosis of pancreatic cancer patients has highlighted a ... which is not being met by the current market. ... array of products with varying molecule types and mechanisms ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... (NYSE: A) today announced that it has for the ... annotation information for all of its microarrays. The release ... research and cross-platform data comparison. , "Full release of ... for Agilent to take," said Catherine Ball, president of ...
... with huge 10 centimetre-long nails spoke volumes. But now definitive ... sighting of a grizzly bear. The discovery fuels mounting evidence ... of the polar bear -- Nanuk is having to make ... barren ground grizzly bear (Ursus arctos) was discovered on Melville ...
... growth of the earliest cities in northern China starting ... the result of successful rice farming combined with other ... Although we often associate rice with Chinese agriculture, most ... that was the most important food associated with northern ...
Cached Biology News:Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays 2Grizzlies set to invade high Arctic? 2
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... The ... and in-depth study on the current state of the global Propanol market with a ... Sinopec, CNPC, BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch ...
(Date:7/30/2015)... , CA (PRWEB) , ... July 30, 2015 ... ... the successful completion of a field clinical study of its canine osteoarthritis stem ... together with Aratana Therapeutics (Kansas City, KS) and will be marketed in the ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015   Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... supply industries, today reported financial results for the second ... half of 2015, we remain on track to achieve ... and Chief Executive Officer of the Company. "Since our ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... July 30 Varian, Inc.,(NasdaqGS: VARI) announced today ... The TPS-compact provides plug-and-play, hydrocarbon free,ultra-high vacuum pumping ... a,light (max weight 19.1kg/42.1lbs.) scroll pump., The ... by,either the Turbo-V 81 MacroTorr(TM) or Turbo-V 301 ...
... July 30 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:,MS), a ... today,announced that Mr. Kevin Giese, President and CEO, will ... in New York., WHEN: Wednesday August ... Broadway Hotel, New York About BioMS Medical Corp., ...
... , - Shares Acquired From Biggar Limited, ... company,focused on eye disease, vascular disease and cancer, ... in Belgium have together acquired an 8%,stake in ... Limited, a,charitable foundation that is ThromboGenics largest shareholder. ...
Cached Biology Technology:New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum. 2BioMS Medical to present at BMO Healthcare Conference 2ThromboGenics Announces Private Investors Acquire 8% Stake in the Company 2ThromboGenics Announces Private Investors Acquire 8% Stake in the Company 3
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Biology Products: